Skip to main content

Table 1 Overview of the patients included in this study. “n=” Indicates the number of patients. FX = fractions; GTV = Gross Tumor Volume, PTV = Planning Target Volume, OAR = Organ at Risk

From: Treatment plan quality during online adaptive re-planning

Treatment

Number of treatments

Fractionation

Treatment technique

Total number of FX

Optimization method

GTV median

[range] (cm3)

PTV median

[range] (cm3)

OAR

Planned

Delivered

Full

Weight

 

Abdomen

18

  

84

81

52 (64%)

29 (36%)

   

 Pancreas

3

5*6.6 Gy (n = 2)

5*8.0 Gy (n = 1)

SBRT (n = 3)

15

15

13

2

16.1 [1.4–53.9]

45.5 [8.7–78.8]

Duodenum (n = 1)

Bowel (n = 1)

Stomach (n = 1)

 Kidney

2a

5*6.0 Gy (n = 1)

5*8.0 Gy (n = 1)

SBRT (n = 2)

9

9

5

4

14.1 [2.1–26.0]

37.5 [8.4–66.6]

Bowel (n = 1)

 Adrenal gland

5

5*6.0 Gy (n = 3)

5*7.0 Gy (n = 2)

SBRT (n = 5)

25

22d

10

12

20.7 [11.2–30.2]

59.8 [33.2–105.7]

Duodenum (n = 2)

Bowel (n = 3)

 Abdomen, other

8

2*5.0 Gy (n = 1)

3*3.0 Gy (n = 1)

5*6.0 Gy (n = 2)

5*6.6 Gy (n = 1)

5*7.0 Gy (n = 1)

5*8.0 Gy (n = 1)

5*9.0 Gy (n = 1)

non-SBRT (n = 1)

SBRT (n = 7)

35

35

24

11

8.7 [2.2–58.9]

27.8 [10.6–92.2]

Duodenum (n = 1)

Bowel (n = 3)

Stomach (n = 3)

Prostate

13

  

55

55

32 (58%)

22 (40%)

   

 Prostate SBRT

8

1*5.0 Gy (n = 1)

5*7.0 Gy (n = 1)

5*7.25 Gy (n = 6)

SBRT (n = 8)

36

36

27

9

29.2 [1.9–50.5]

29.2 [11.8–86.2]

Rectum (n = 8)

Bladder (n = 8)

 Prostate IMRT

5

3*2.0 Gy (n = 3)

4*2.0 Gy (n = 1)

6*2.0 Gy (n = 1)

non-SBRT (n = 5)

19

19

5

13

1.8 [0.77–3.3]

11.3 [5.7–12.1]

Rectum (n = 5)

Bladder (n = 5)

Lung

10b

3*10 Gy (n = 1)

3*12.5 Gy (n = 3)

5*8.0 Gy (n = 1)

5*9.0 Gy (n = 3)

8*6.0 Gy (n = 2)

SBRT (n = 10)

48

48

28 (58%)

13 (27%)

4.1 [0.54–67.6]

17.1 [4.6–131.3]

 

Liver

9

  

38

38

31 (82%)

7 (18%)

   

 Liver SBRT

5a

5*6.0 Gy (n = 1)

5*9.0 Gy (n = 3)

6*5.0 Gy (n = 1)

SBRT (n = 5)

26

26

21

5

25.5 [6.8–122.2]

67.4 [37.0–292.2]

Bowel (n = 1)

 Liver IMRT

4

3*3.0 Gy (n = 4)

non-SBRT (n = 4)

12

12

10

2

20.2 [10.9–27.8]

75.7 [46.8–100.3]

Duodenum (n = 4)

Pelvis

5c

5*6.5 Gy (n = 1)

5*7.0 Gy (n = 4)

SBRT (n = 5)

25

25

10 (40%)

14 (56%)

4.3 [0.32–5.4]

12.7 [2.5–19.3]

Bowel (n = 2)

  1. aOne patient had two lesions: kidney and liver
  2. bOne patient had two lung lesions
  3. cOne patient had two pelvis lesions
  4. dPatient continued treatment on conventional linac